骨蠟市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、應用、最終用途、地區和細分市場進行的預測

Bone Wax Market Size, Share & Trends Analysis Report By Product (Absorbable, Non-absorbable), By Application (Orthopedic Surgery, Thoracic Surgery), By Material, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年02月19日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

骨蠟市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球骨蠟市場規模將達到6,600萬美元，2024年至2030年複合年成長率為3.1%。

全球骨折發生率的增加是推動產品使用的主要因素。骨質疏鬆症是骨折的主要危險因子之一，尤其是髖部、腕部和脊椎骨折。根據國際骨質疏鬆基金會預測，到2050年，亞洲人口的骨質疏鬆盛行率預計將超過50%。因此，骨質疏鬆症盛行率的增加預計將有助於市場成長。此外，關節炎盛行率的增加預計將推動該行業的成長。關節炎會導致骨質劣化，進一步增加骨折的風險。根據健康指標與評估研究所的數據，到 2050 年，骨關節炎（關節炎的常見形式）的全球盛行率預計將達到 10 億人。

Elsevier BV（Science Direct）於 2021 年 2 月發表的一項研究發現，在英國，患有骨關節炎的人骨折盛行率為每1000 人13.2 人，而沒有骨關節炎的人骨折盛行率為每1000 人13.2 人。人類盛行率為每1000 人8.5 人。人們對牙科護理意識的不斷提高以及重組和植入手術的增加正在推動對牙科/口腔手術應用產品的需求。根據世界衛生組織2023年3月發表的論文，全球口腔疾病的人數約為35億人。此外，口腔癌引起的口腔手術數量的增加預計將推動市場成長。例如，根據全球癌症觀察站的數據，2022 年將發現 389,495 例新的唇癌和口腔癌病例。

骨蠟市場報告亮點

由於不可吸收骨產品在整形外科和顱顏手術中的應用，到 2023 年，不可吸收骨產品領域將佔據超過 65.0% 的市場佔有率。由於可吸收骨產品在關節成形術中的廣泛採用，預計從 2024 年到 2030 年，可吸收骨產品領域將以最快的複合年成長率成長。
整形外科部門在2023年佔據最大的收益佔有率，由於患有整形外科疾病的老年人口不斷增加，預計2024年至2030年將以最快的複合年成長率成長。
天然材料領域預計將在 2023 年佔據市場主導地位，並由於其與人體自然癒合機制的兼容性，在 2024 年至 2030 年期間以最快的複合年成長率成長。
醫院終端使用領域因其在提供全面醫療服務方面的作用而在市場中佔據主導地位。由於門診病人手術的需求旺盛，預計 2024 年至 2030 年門診病人設施領域的複合年成長率最快。
由於人口參與體育和休閒的增加以及由此導致的骨折病例增加等因素，北美在 2023 年將引領市場。
2023 年 9 月，Abyrx, Inc. 獲得美國FDA 監管部門批准 MONTAGE 可固化骨泥用於心胸外科手術。這是 FDA 首次批准在胸骨切開術中使用可固化骨泥。

2023 年及 2030 年區域市場佔有率分析
區域市場儀表板
全球區域市場概況
2018-2030年市場規模及預測趨勢分析：
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 挪威
- 瑞典
- 丹麥
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 泰國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東/非洲
- 南非
- 沙烏地阿拉伯
- UAE
- 科威特

第9章競爭形勢

主要市場參與企業的最新趨勢和影響分析
公司/競爭對手分類
供應商形勢
- Key customers
- Key company market share analysis, 2023
- Braun Melsungen AG
- Baxter International Inc.
- Johnson &Johnson
- Medtronic plc
- GPC Medical Ltd
- Medline Industries Inc
- Dolphin Sutures
- SMI AG
- ORION SUTURES INDIA PVT LTD
- Universal Sutures

簡介目錄圖表

Product Code: GVR-4-68040-197-6

Bone Wax Market Growth & Trends:

The global bone wax market size is anticipated to reach USD 66.0 million by 2030, registering a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing incidence of fractures globally is the major factor driving product usage. Osteoporosis is one of the major risk factors resulting in fractures, especially in the hip, wrist, or spine. According to the International Osteoporosis Foundation, by 2050, the Asian population is expected to have over 50% prevalence of osteoporosis. Hence, increasing osteoporosis prevalence is expected to contribute to the market growth. Furthermore, the increasing prevalence of arthritis is expected to drive industry growth. Arthritis results in degrading bone quality, which further increases the risk of fractures. According to the Institute for Health Metrics and Evaluation, by 2050, the global prevalence of osteoarthritis, a common form of arthritis, is expected to reach 1 billion.

According to the Elsevier B.V. (Science Direct) study published in February 2021, in the UK, the prevalence of fractures in osteoarthritis individuals was 13.2 per 1000 individuals, whereas, in non-osteoarthritis individuals, the prevalence was 8.5 per 1000 individuals. Increasing dental health awareness and a growing number of reconstructive and implant surgeries fuel product demand in dental/oral surgery applications. According to the WHO article published in March 2023, the global prevalence of oral diseases is approximately 3.5 billion. Moreover, the rising volume of oral surgeries due to oral cancer is expected to drive market growth. For instance, according to the Global Cancer Observatory, in 2022, 389,495 new cases of lip and oral cancer were detected.

Bone Wax Market Report Highlights:

The non-absorbable bone product segment led the market with a share of more than 65.0% share in 2023 owing to its application in orthopedics and craniofacial surgeries. The absorbable bone segment is expected to grow at the fastest CAGR from 2024 to 2030 owing to the high adoption of these products in arthroplasty procedures
The orthopedic surgery segment held the largest revenue share in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030 due to rising geriatric population suffering from orthopedic disorders
The natural material segment dominated the market in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030 owing to its compatibility with the body's natural healing mechanisms
The hospital end-use segment dominated the market owing to its role in the delivery of comprehensive healthcare services. The outpatient facility segment is expected to register the fastest CAGR from 2024 to 2030 due to the high demand for outpatient surgeries
North America led the market in 2023 due to factors such as the growing participation of the population in sports and recreational activities, and a resultant rise in the cases of bone fractures
In September 2023, Abyrx, Inc. received a regulatory clearance from the U.S. FDA for its MONTAGE Settable Bone Putty, used in cardiothoracic surgery. It is the first clearance by the FDA to use settable bone putty in sternotomy

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Material
- 1.2.4. End-use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Material outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Bone Wax Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing incidence of sport-related injuries
  - 3.2.1.2. Increasing prevalence of orthopedic disorders
  - 3.2.1.3. Growing geriatric population and increasing adoption of absorbable bone wax products in arthroplasty procedures
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High development and maintenance costs
3.3. Bone Wax Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic Landscape

Chapter 4. Bone Wax Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Bone Wax Market Movement Analysis, by Product (2023 & 2030)
4.3. Global Bone Wax Market by Product Outlook (2018 - 2030) (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Absorbable bone wax
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Non-absorbable bone wax
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Bone Wax Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Bone Wax Market Movement Analysis, by Application (2023 & 2030)
5.3. Global Bone Wax Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Orthopedic surgery
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Thoracic surgery
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Neurosurgery
- 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Dental/oral surgery
- 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
- 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Bone Wax Market: Material Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Bone Wax Market Movement Analysis, by Material (2023 & 2030)
6.3. Global Bone Wax Market by Material Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Natural bone wax
- 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Synthetic bone wax
- 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Bone Wax Market: End-use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Bone Wax Market Movement Analysis, by End Use (2023 & 2030)
7.3. Global Bone Wax Market by End-use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospitals
- 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Outpatient facilities
- 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Bone Wax Market: Regional Estimates & Trend Analysis, by Product, Application, Material, and End Use 2018 - 2030 (USD Million)

8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
- 8.5.1. U.S.
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework/ reimbursement structure
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework/ reimbursement structure
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
- 8.6.1. UK
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework/ reimbursement structure
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework/ reimbursement structure
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework/ reimbursement structure
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework/ reimbursement structure
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework/ reimbursement structure
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Norway
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework/ reimbursement structure
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Regulatory framework/ reimbursement structure
  - 8.6.7.3. Competitive scenario
  - 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Denmark
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Regulatory framework/ reimbursement structure
  - 8.6.8.3. Competitive scenario
  - 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
- 8.7.1. Japan
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework/ reimbursement structure
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework/ reimbursement structure
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework/ reimbursement structure
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
  - 8.7.4.1. Key country dynamics
  - 8.7.4.2. Regulatory framework/ reimbursement structure
  - 8.7.4.3. Competitive scenario
  - 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
  - 8.7.5.1. Key country dynamics
  - 8.7.5.2. Regulatory framework/ reimbursement structure
  - 8.7.5.3. Competitive scenario
  - 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
  - 8.7.6.1. Key country dynamics
  - 8.7.6.2. Regulatory framework/ reimbursement structure
  - 8.7.6.3. Competitive scenario
  - 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
- 8.8.1. Brazil
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework/ reimbursement structure
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Mexico
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework/ reimbursement structure
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Argentina
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory framework/ reimbursement structure
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
- 8.9.1. South Africa
  - 8.9.1.1. Key country dynamics
  - 8.9.1.2. Regulatory framework/ reimbursement structure
  - 8.9.1.3. Competitive scenario
  - 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
  - 8.9.2.1. Key country dynamics
  - 8.9.2.2. Regulatory framework/ reimbursement structure
  - 8.9.2.3. Competitive scenario
  - 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
  - 8.9.3.1. Key country dynamics
  - 8.9.3.2. Regulatory framework/ reimbursement structure
  - 8.9.3.3. Competitive scenario
  - 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
  - 8.9.4.1. Key country dynamics
  - 8.9.4.2. Regulatory framework/ reimbursement structure
  - 8.9.4.3. Competitive scenario
  - 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
- 9.3.1. Key customers
- 9.3.2. Key company market share analysis, 2023
- 9.3.3. Braun Melsungen AG
  - 9.3.3.1. Company overview
  - 9.3.3.2. Financial performance
  - 9.3.3.3. Product benchmarking
  - 9.3.3.4. Strategic initiatives
- 9.3.4. Baxter International Inc.
  - 9.3.4.1. Company overview
  - 9.3.4.2. Financial performance
  - 9.3.4.3. Product benchmarking
  - 9.3.4.4. Strategic initiatives
- 9.3.5. Johnson & Johnson
  - 9.3.5.1. Company overview
  - 9.3.5.2. Financial performance
  - 9.3.5.3. Product benchmarking
  - 9.3.5.4. Strategic initiatives
- 9.3.6. Medtronic plc
  - 9.3.6.1. Company overview
  - 9.3.6.2. Financial performance
  - 9.3.6.3. Product benchmarking
  - 9.3.6.4. Strategic initiatives
- 9.3.7. GPC Medical Ltd
  - 9.3.7.1. Company overview
  - 9.3.7.2. Financial performance
  - 9.3.7.3. Product benchmarking
  - 9.3.7.4. Strategic initiatives
- 9.3.8. Medline Industries Inc
  - 9.3.8.1. Company overview
  - 9.3.8.2. Financial performance
  - 9.3.8.3. Product benchmarking
  - 9.3.8.4. Strategic initiatives
- 9.3.9. Dolphin Sutures
  - 9.3.9.1. Company overview
  - 9.3.9.2. Financial performance
  - 9.3.9.3. Product benchmarking
  - 9.3.9.4. Strategic initiatives
- 9.3.10. SMI AG
  - 9.3.10.1. Company overview
  - 9.3.10.2. Financial performance
  - 9.3.10.3. Product benchmarking
  - 9.3.10.4. Strategic initiatives
- 9.3.11. ORION SUTURES INDIA PVT LTD
  - 9.3.11.1. Company overview
  - 9.3.11.2. Financial performance
  - 9.3.11.3. Product benchmarking
  - 9.3.11.4. Strategic initiatives
- 9.3.12. Universal Sutures
  - 9.3.12.1. Company overview
  - 9.3.12.2. Financial performance
  - 9.3.12.3. Product benchmarking
  - 9.3.12.4. Strategic initiatives